SDHD and neoplasm: In our study, the patients developed a tumor at the maximum age of 69 years, which accords with a larger study at the LUMC from 2011, presenting a maximum risk of 87% at the age of 70 in SDHD pathogenic variant carriers.17This could argue for reducing the screening frequency or even discontinuing the screening in older patients.